drugset / Trial / NCT06432075

Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer

NCT06432075

Phase 0 Not yet recruiting 20 enrolled First Affiliated Hospital of Wenzhou Medical University
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to see the safety and efficient of neoantigen reactive T cells (NRTs) in the treatment of Chinese patients with advanced gastric cancer.

Timeline

Start
2024-06-01
Primary completion
2026-01-01
Completion
2026-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Neoantigen Reactive T Cells Cell therapy 5e+09 cells Intravenous
Subject Neoantigen Reactive T Cells Cell therapy 1e+10 cells Intravenous

Indications